華業香料(300886.SZ):擬使用募集資金1.68億元對全資子公司合肥華業增資
格隆匯 9 月 25日丨華業香料(300886.SZ)公告,公司於2020年9月23日召開第三屆董事會第十四次會議和第三屆監事會第十一次會議,審議通過了《關於使用募集資金對全資子公司增資實施募投項目的議案》,同意公司使用募集資金1.68億元向全資子公司安徽華業香料合肥有限公司(以下簡稱“合肥華業”)進行增資,用於實施“年產3000噸丙位內酯系列合成香料建設項目”,其中人民幣3000萬元用於增加合肥華業的註冊資本,其餘部分計入合肥華業資本公積。本次增資完成後,合肥華業註冊資本將由人民幣7000萬元增加至人民幣1億元,仍為公司全資子公司。
本次增資事項尚需提交股東大會審議批准。本次增資未構成關聯交易,也未構成《上市公司重大資產重組管理辦法》規定的重大資產重組。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.